MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

MetLife, Inc. $MET Shares Purchased by Cantor Fitzgerald Investment Advisors L.P. - MarketBeat

Dividend Earnings report Share buyback AI-generated analysis

πŸ“ˆ MetLife reported quarterly EPS of $2.43, beating estimates by $13 cents, with revenue rising 10.5% year-over-year to $13.52 billion.

πŸ’° The company announced a new $3 billion share repurchase authorization and declared a quarterly dividend of $0.5925 per share.

πŸ“Š Institutional ownership remains high at 94.99%, with Cantor Fitzgerald increasing its stake by 19.5% to own roughly 206,000 shares.

🏦 Robeco Institutional Asset Management B.V. significantly boosted its position by 159.3%, adding over 135,000 shares to its portfolio.

πŸ“ˆ Analyst consensus is a 'Moderate Buy' with an average price target of $105.44, supported by recent upgrades from TD Cowen and Wells Fargo.

πŸ“‰ Mizuho lowered its price target to $109, though the stock remains above its 50-day moving average of $97.12.

πŸ’΅ MetLife maintains a debt-to-equity ratio of 0.52 and a payout ratio of 45.40% on its current dividend.

Bullish Signals
  • MetLife reported quarterly EPS of $2.43, beating analyst estimates by $0.13, demonstrating solid operational performance.
  • The company secured a new $3 billion share repurchase authorization, signaling management confidence in the stock's valuation and commitment to capital return.
  • Cantor Fitzgerald Investment Advisors increased its stake by 19.5% in the third quarter, adding 33,557 shares to its holdings.
  • Robeco Institutional Asset Management B.V. aggressively expanded its position by 159.3%, acquiring an additional 135,186 shares.
  • TD Cowen raised its price target on MetLife from $110.00 to $114.00 and reaffirmed a 'buy' rating.
  • Wells Fargo & Company upgraded its outlook with an 'overweight' rating and raised the price target to $110.00.
  • MetLife declared a quarterly dividend of $0.5925 per share, providing investors with a 2.3% annualized yield.
Risk Factors
  • MetLife's quarterly revenue of $13.52 billion missed the consensus analyst estimate of $19.67 billion.
  • Mizuho lowered its price target on MetLife from $112.00 to $109.00, indicating some caution among analysts.
Full Analysis
MetLife, Inc. (NYSE: MET) reported quarterly earnings of $2.43 per share, beating analyst estimates by $0.13. The company generated revenue of $13.52 billion for the quarter, representing a 10.5% year-over-year increase, though this fell short of the consensus expectation of $19.67 billion. Financial metrics showed a return on equity of 23.39% and a net margin of 4.57%. The stock currently trades with a market capitalization of $65.86 billion and a price-to-earnings ratio of 10.36. Following the earnings release, MetLife's Board of Directors authorized a new share repurchase program allowing the company to buy back up to $3 billion in shares, which represents approximately 4.8% of its outstanding stock. Additionally, the company declared a quarterly dividend of $0.5925 per share, payable on December 8th to shareholders of record as of November 3rd, offering an annualized yield of 2.3%. Institutional investor sentiment remains broadly positive, with Cantor Fitzgerald Investment Advisors increasing its stake by 19.5% in the third quarter to own approximately 206,000 shares valued at $19.4 million. Other notable institutional activity includes significant position increases from Robeco Institutional Asset Management B.V., which boosted its holdings by 159.3%, and Nisa Investment Advisors LLC, which raised its position by 1.7%. Wall Street analysts maintain a consensus 'Moderate Buy' rating on MetLife with an average price target of $105.44. Recent analyst actions include Wells Fargo & Company raising its target price to $110 and TD Cowen increasing its target to $114, while Mizuho lowered its target to $109. The stock has a beta of 0.78 and is trading above its 50-day and 200-day moving averages.